Litigation Details for Delcor Asset Corporation v. Glenmark Pharmaceuticals Limited (D. Del. 2017)

Delcor Asset Corporation v. Glenmark Pharmaceuticals Limited (D. Del. 2017)

Docket		Date Filed	2017-11-15
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To
Jury Demand	None	Referred To
Patents	7,141,237; 7,374,747
Link to Docket	External link to docket

Details for Delcor Asset Corporation v. Glenmark Pharmaceuticals Limited (D. Del. 2017)

Date Filed	Document No.	Description	Snippet	Link To Document
2017-11-15	1		United States Patent Nos. 7,141,237 (“the ’237 patent”) and 7,374,747 (“the ’747 patent”) arising under… INFRINGEMENT OF U.S. PATENT NO. 7,141,237 40. Delcor repeats and realleges…DECLARATORY JUDGMENT OF INFRINGEMENT OF U.S. PATENT NO. 7,141,237 45. Delcor repeats and realleges… THE PATENTS-IN-SUIT 14. The ’237 patent, titled “Pharmaceutical Foam…forth in greater detail in the ’237 patent, the claims of the ’237 patent, incorporated by reference herein	External link to document
2017-11-15	4		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,141,237; 7,374,747. (nmfn) …15 November 2017 1:17-cv-01653-RGA Patent - Abbreviated New Drug Application(ANDA)	External link to document
2018-10-31	93		multiple terms in U.S . Patent Nos. 7,141 ,237 ("the '237 patent") and 7,374,747 ("…construction for multiple terms in U.S. Patent Nos. 7,141,237 and 7,374,747. Signed by Judge Richard G… Ill. PATENTS AT ISSUE The '747 patent is a continuation of the '237 patent and the … 237 and ' 747 patents. (D.I. 1 ,r,r 19- 20). Stiefel owns the asserted patents but was joined as …quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which	External link to document